Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Morphine Sulfate 20 MG Extended Release Oral Capsule [Kadian]

Known as: MORPHINE SULFATE 20 mg ORAL CAPSULE, EXTENDED RELEASE [KADIAN], Kadian 20 MG Extended Release Oral Capsule, MS 20 MG Extended Release Oral Capsule [Kadian] 
 
National Institutes of Health

Related topics

Related topics

21 relations
Extended Release Oral CapsuleGelatinKadianMETHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
High-Alert Medications
High-alert drugs pose a significant threat to patient safety. There are safeguards that pharmacists should put in place to reduce… Expand
Is this relevant?
2011
2011
The Relative Bioavailability of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules (EMBEDA®) and an Extended Release Morphine Sulfate Capsule Formulation (KADIAN®) in Healthy…
Morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®, King Pharmaceuticals®, Inc., Bristol, TN… Expand
Is this relevant?
2007
2007
(758): In vivo pharmacokinetics of KADIAN® (morphine sulfate extended-release) capsules taken with alcohol
 
Is this relevant?
2005
2005
A head-to-head, single-dose trial of KADIAN® vs AVINZA® 30mg in healthy, opioid-naïve subjects in the fed state: Comparison of pharmacokinetics
 
Is this relevant?
2005
2005
Treatment of neuropathic pain with KADIAN® in poor responders to other pain medications
 
Is this relevant?
2004
2004
Opioids in non-cancer pain: Improved quality of life with Kadian® (morphine sulfate sustained-release capsules) in patients with chronic, non-malignant, moderate/severe pain: The KRONUS-MSP trial
 
Is this relevant?
2004
2004
Opioids in non-cancer pain: Kadian® (morphine sulfate sustained-release capsules) is effective and safe for elderly patients with chronic, non-malignant, moderate/severe pain: The KRONUS-MSP trial
 
Is this relevant?
2000
2000
A Patient Preference Study Comparing Two Extended-Release Morphine Sulfate Formulations (Once-Daily Kadian® versus Twice-Daily MS Contin®) for Cancer Pain
AbstractObjective: To compare pain control, patient preference and tolerability for two extended-release ® capsules (administered… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain.
Kadian/Kapanol (K) is a capsule formulation of morphine designed for 12- or 24-hourly dosing. This double-blind study compared… Expand
Is this relevant?
1997
1997
Comparative Bioavailability of Sustained-Release Morphine Sulfate Capsules versus Pellets
SummaryKadian™ is an oral formulation of sustained-release morphine sulfate pellets contained in a gelatin capsule, indicated for… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE